andMe · conference-presentation
23andMe | Investor Day Presentation Deck | 78 slides
78 pages · 5 arc beats · 2 loops
23andMe | Investor Day Presentation Deck | 78 slides
andMe · 2022-01 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
15101520253035404550556065707578
Deck intelligence map
5 coverage by narrative range · generated from this deck JSON
Narrative range 49 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Situation & Context 4 slides 100% 4/4 slides 100% 4/4 slides · 11 hits — 0/4 slides
75% 3/4 slides 25% 1/4 slides 100% 4/4 slides — 0/4 slides
Problem & Complication 2 slides 100% 2/2 slides 100% 2/2 slides · 13 hits — 0/2 slides
100% 2/2 slides · 3 hits 50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Solution & Approach 8 slides 100% 8/8 slides 100% 8/8 slides · 36 hits — 0/8 slides
37.5% 3/8 slides · 4 hits 50% 4/8 slides 100% 8/8 slides — 0/8 slides
Evidence & Proof 10 slides 100% 10/10 slides 100% 10/10 slides · 52 hits — 0/10 slides
40% 4/10 slides · 5 hits 50% 5/10 slides 100% 10/10 slides — 0/10 slides
Impact & Next Steps 25 slides 100% 25/25 slides 100% 25/25 slides · 104 hits — 0/25 slides
52% 13/25 slides · 15 hits 24% 6/25 slides 100% 25/25 slides — 0/25 slides
Slide inventory
78 every slide · same image gating as the playbook
07
The slide uses a bar chart to compare 23andMe's 11.9M participants against other biobanks and research programs.size_opportunity
08
The slide uses a circular process flow to represent a self-reinforcing business model.present_framework
11
The slide uses a split-screen layout with a blue background on the left for the thesis and a white background on the right for supporting metrics.diagnose_problem
12
The slide uses a contrast-pairs framework to show the advantage of genetic evidence in drug development.compare_peers
13
Uses a process flow diagram to explain the company's core R&D methodology.plan_implementation
Open slide detailBeat · Solution & Approach
14
The slide highlights the scale of the 23andMe database for medical research.analyze_data
Open slide detailBeat · Solution & Approach
15
The slide uses a timeline-style layout to show drug development progress.present_framework
Open slide detailBeat · Solution & Approach
19
Uses a 'bench to bedside' bidirectional flow model to explain drug development strategy.present_framework
Open slide detailBeat · Solution & Approach
20
The slide uses a funnel metaphor to show the narrowing of research focus from broad data to specific drug targets.present_solution
Open slide detailBeat · Solution & Approach
21
The slide uses a heatmap-style visualization to show opposing effects of genes on immune vs cancer phenotypes.present_framework
Open slide detailBeat · Evidence & Proof
22
Includes an immunohistochemistry image showing CD200 expression and a schematic diagram of the antibody mechanism.present_solution
Open slide detailBeat · Evidence & Proof
23
The slide uses a circular flow diagram to represent a business flywheel model.present_framework
Open slide detailBeat · Evidence & Proof
25
Includes a Manhattan plot and a zoomed-in regional association plot.establish_context
Open slide detailBeat · Evidence & Proof
26
The slide uses Manhattan plots to show the density of genetic associations increasing over time, paired with a line chart showing the cumulative growth of indepquantify_opportunity
Open slide detailBeat · Evidence & Proof
27
Uses a 'fill in the blanks' analogy to explain a technical process.present_framework
Open slide detailBeat · Evidence & Proof
28
Includes a visual process diagram of imputation and a before/after Manhattan plot comparison.present_solution
Open slide detailBeat · Evidence & Proof
29
The slide uses a Venn diagram to illustrate the overlap between two gene discovery methods.analyze_data
Open slide detailBeat · Evidence & Proof
30
The slide uses a grid of small heatmaps/bar charts to visualize data across 10 medical categories. A specific example for NAFLD is highlighted at the bottom.analyze_data
Open slide detailBeat · Evidence & Proof
31
The heatmap shows statistical significance of associations with O blood type, with red indicating increased risk and blue indicating decreased risk.present_framework
32
The slide illustrates a PheWAS (Phenome-wide association study) approach using a similarity classifier to identify genes matching a known CTLA4 immuno-oncology present_framework
34
The slide uses a three-part flow: market size (left), industry landscape (center), and 23andMe's proprietary identification method (right).size_opportunity
Open slide detailLoop · Quick Win Big Bet
35
The slide uses heatmaps to visualize genetic associations with various phenotypes, highlighting the CD200R1 pathway.analyze_data
Open slide detailLoop · Quick Win Big Bet
36
The slide uses a biological pathway diagram to illustrate the mechanism of action.diagnose_problem
Open slide detailLoop · Quick Win Big Bet
37
The slide uses a before-after visual to illustrate the mechanism of action.present_solution
Open slide detailLoop · Quick Win Big Bet
38
The slide uses a bar chart to demonstrate efficacy across 9 different patient samples (Endometrial, Ovarian, Lung, Melanoma, Pancreatic, Prostate, Colorectal).analyze_data
Open slide detailLoop · Quick Win Big Bet
39
Clinical trial design schematic showing patient population, study parts (A and B), and primary/secondary objectives.present_framework
Open slide detailLoop · Quick Win Big Bet
40
The slide uses visual evidence (microscopy) to support the thesis of co-expression.illustrate_case
Open slide detailLoop · Quick Win Big Bet
44
The slide uses heatmaps to show genetic associations (signed log(p)) for CTLA4 and CD96/CD226 pathways.analyze_data
45
The slide uses a biological interaction map to explain the rationale for combination therapy.present_framework
46
The chart shows tumor volume over time for various monotherapy and combination therapy groups, highlighting the triple combination's efficacy.analyze_data
47
Includes a process flow diagram for study arms and a table for endpoints.present_framework
50
The slide uses a large circular graphic to focus attention on the central question.frame_problem
51
The slide outlines the 23andMe pipeline from sample collection to FDA-authorized reporting.present_solution
52
The slide presents a collection of survival curves and hazard ratio plots from various clinical trials and academic publications.analyze_data
56
The slide uses a donut chart to visualize the breakdown of health determinants.establish_context
Open slide detailBeat · Impact & Next Steps
57
The slide uses a simple equation-style visual (A + B = C) to represent a business merger or partnership.present_solution
Open slide detailBeat · Impact & Next Steps
61
The slide uses a circular process flow to represent a self-reinforcing business model.present_framework
Open slide detailBeat · Impact & Next Steps
62
The slide uses a grid layout to categorize service offerings with representative mobile app UI screenshots for each category.summarize
Open slide detailBeat · Impact & Next Steps
63
Includes a Manhattan plot and a zoomed-in regional association plot.present_framework
Open slide detailBeat · Impact & Next Steps
64
The slide uses a linear process flow to explain the methodology behind polygenic risk scoring.present_framework
Open slide detailBeat · Impact & Next Steps
65
The chart illustrates the predictive validity of polygenic risk scores for BMI.analyze_data
Open slide detailBeat · Impact & Next Steps
66
The slide displays a UI mockup of a personalized health report.illustrate_case
Open slide detailBeat · Impact & Next Steps
67
The slide uses a vertical timeline format to list specific health conditions released in each fiscal year.present_solution
Open slide detailBeat · Impact & Next Steps
68
The slide uses a process flow diagram to explain the value proposition of 23andMe's predictive health platform.present_solution
Open slide detailBeat · Impact & Next Steps
69
PGS stands for Polygenic Score. The chart shows cumulative incidence rate over age onset for different risk percentiles.analyze_data
Open slide detailBeat · Impact & Next Steps
70
The chart shows cumulative incidence rates of T2D over age, comparing different risk/lifestyle profiles.analyze_data
Open slide detailBeat · Impact & Next Steps
71
Uses a visual contrast between uniform yellow figures (reactive) and diverse, multi-colored figures (proactive) to illustrate the shift from one-size-fits-all tframe_problem
Open slide detailBeat · Impact & Next Steps
73
The slide uses a horizontal line to suggest a unified platform or process flow connecting the three service pillars.present_solution
Open slide detailBeat · Impact & Next Steps
74
Shows a user interface for health goal selection and genetic risk reporting, paired with a clinician profile.present_solution
Open slide detailBeat · Impact & Next Steps